| Product Code: ETC7623457 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continues to see a diverse range of countries exporting Aripiprazole, with China, Singapore, UK, USA, and Netherlands leading the way. The Herfindahl-Hirschman Index (HHI) indicates a low concentration of imports, reflecting a competitive market. A strong compound annual growth rate (CAGR) of 10.73% from 2020 to 2024 demonstrates sustained expansion. Notably, the impressive growth rate of 44.88% in 2024 signifies a significant uptick in Aripiprazole imports, showcasing the growing demand and market opportunities in Ireland for this pharmaceutical product.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Aripiprazole Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Aripiprazole Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Aripiprazole Market - Industry Life Cycle |
3.4 Ireland Aripiprazole Market - Porter's Five Forces |
3.5 Ireland Aripiprazole Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Aripiprazole Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Aripiprazole Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Ireland Aripiprazole Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 Ireland Aripiprazole Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Ireland Aripiprazole Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Aripiprazole Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of mental health disorders in Ireland |
4.2.2 Growing awareness and acceptance of mental health treatment |
4.2.3 Rise in government initiatives to support mental health programs |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for aripiprazole products |
4.3.2 High competition from other antipsychotic medications |
4.3.3 Adverse side effects associated with aripiprazole usage |
5 Ireland Aripiprazole Market Trends |
6 Ireland Aripiprazole Market, By Types |
6.1 Ireland Aripiprazole Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Aripiprazole Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ireland Aripiprazole Market Revenues & Volume, By Antipsychotics, 2021- 2031F |
6.1.4 Ireland Aripiprazole Market Revenues & Volume, By Antimanic Agents, 2021- 2031F |
6.2 Ireland Aripiprazole Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Aripiprazole Market Revenues & Volume, By Major Depressive Disorders, 2021- 2031F |
6.2.3 Ireland Aripiprazole Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.2.4 Ireland Aripiprazole Market Revenues & Volume, By Bipolar Mania, 2021- 2031F |
6.2.5 Ireland Aripiprazole Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Aripiprazole Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Ireland Aripiprazole Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Ireland Aripiprazole Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Ireland Aripiprazole Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Ireland Aripiprazole Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.3 Ireland Aripiprazole Market Revenues & Volume, By Orally Disintegrating Tablets, 2021- 2031F |
6.4.4 Ireland Aripiprazole Market Revenues & Volume, By Oral Solution, 2021- 2031F |
6.4.5 Ireland Aripiprazole Market Revenues & Volume, By Injection, 2021- 2031F |
6.5 Ireland Aripiprazole Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Ireland Aripiprazole Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Ireland Aripiprazole Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Ireland Aripiprazole Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Ireland Aripiprazole Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Ireland Aripiprazole Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Ireland Aripiprazole Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Ireland Aripiprazole Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Ireland Aripiprazole Market Import-Export Trade Statistics |
7.1 Ireland Aripiprazole Market Export to Major Countries |
7.2 Ireland Aripiprazole Market Imports from Major Countries |
8 Ireland Aripiprazole Market Key Performance Indicators |
8.1 Patient adherence rate to aripiprazole treatment |
8.2 Number of healthcare professionals prescribing aripiprazole |
8.3 Frequency of mental health awareness campaigns in Ireland |
9 Ireland Aripiprazole Market - Opportunity Assessment |
9.1 Ireland Aripiprazole Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Aripiprazole Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Aripiprazole Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Ireland Aripiprazole Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 Ireland Aripiprazole Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Ireland Aripiprazole Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Aripiprazole Market - Competitive Landscape |
10.1 Ireland Aripiprazole Market Revenue Share, By Companies, 2024 |
10.2 Ireland Aripiprazole Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here